ANZUP and PCFA have a common interest in clinical trials relating to prostate cancer so this partnership grant aims to encourage members to consider submitting their ideas/concepts for broader feedback from a multidisciplinary panel including senior investigators, statisticians, consumers and trainees with the aim of becoming an ANZUP sponsored protocol.
ANZUP encourages and supports concepts that are:
- Investigator Initiated ;
- Multidisciplinary;
- Multicentre (ie ideally across multiple ANZUP sites (4-6 minimum);
- Inclusive where appropriate of Quality of Life, Translational Research or Health Economic components;
- Capable of leading to changes in practice
Funding has been awarded to Principal Investigator Associate Professor Shahneen Sandhu for the study:
EVOLUTION: A randomised phase II trial of Radionuclide 177Lu-PSMA Therapy versus 177Lu-PSMA in Combination with Ipilimumab and Nivolumab for Men with Metastatic Castration Resistant Prostate Cancer (mCRPC). (ANZUP 2001)
